Trials / Completed
CompletedNCT00844792
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer
A Randomized, Double-Blind Study of Combination Vitamin E, Selenium and Lycopene vs. Placebo in Men Undergoing Radical Prostatectomy for Prostate Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see if an intervention of antioxidants(vitamin E, selenium and lycopene) can change (reduce) prostate tumor size and alter certain markers that can affect tumor growth and prostate cancer aggressiveness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E | Twice a day with meals. Lycopene - 20 mg, Vitamin D3 - 200 IU, Selenium - 100 mcg, Green Tea Extract - 75 mg, Vitamin E - 50 IU |
| DRUG | Placebo | Twice a day with meals. |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2009-02-16
- Last updated
- 2017-10-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00844792. Inclusion in this directory is not an endorsement.